Ontology highlight
ABSTRACT: Context
Resveratrol has been used for the treatment of endometriosis.Objective
To compare resveratrol (40 mg/d) with monophasic contraceptive pill (COC) to COC with placebo for the reduction of pain scores.Design
A randomized clinical trial.Setting
University Hospital.Patients
Women (ages 20 to 50) with laparoscopic diagnosis of endometriosis were eligible for the study. Exclusion criteria: pregnancy, allergy to resveratrol, or contraindications to COC, use of agonists of gonadotropin release hormone or danazol in the last month, or had used depot medroxyprogesterone acetate or Mirena®.Intervention
Subjects were randomized using a computer-generated randomization list to receive COC for 42 days to be taken with identical capsules containing 4
SUBMITTER: Mendes da Silva D
PROVIDER: S-EPMC5686687 | biostudies-literature | 2017 Apr
REPOSITORIES: biostudies-literature